Longboard Pharmaceuticals

Longboard Pharmaceuticals Stock Price Jumps as Lundbeck A/S Acquires Controlling Stake for $60 per Share

Keshav Seth 15 October 2024
Longboard Pharmaceuticals Stock Price Jumps as Lundbeck A/S Acquires Controlling Stake for $60 per Share

H. Lundbeck A/S, a prominent Danish pharmaceutical company, has announced its largest-ever acquisition, agreeing to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion.